Mixaferrum’s innovative granular formulation features bi-layer technology that includes modified starch, phosphatidylcholine (PC), and phosphatidylserine (PS), demonstrating greater gastroresistance compared to other supplements. These benefits are supported by an in vitro study evaluating gastroresistance and intestinal absorption.
Mixaferrum emerges as a promising therapeutic product for the efficient treatment of iron deficiency.